The Effect of a Single Training Session on Changes in Inflammatory, Hormonal, and Metabolic Markers in Athletes
1 other identifier
observational
5
1 country
1
Brief Summary
The study aims to assess the acute response of wrestlers to a single training session. Short-term changes in inflammatory, hormonal, and metabolic markers are analyzed to assess fatigue development and recovery following intense exercise. Participation in the study involves completing a standard training session and providing blood samples at three time points to assess the physiological response. The results provide a better understanding of the mechanisms underlying adaptation to exercise in competitive wrestlers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Feb 2014
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2014
CompletedFirst Submitted
Initial submission to the registry
November 23, 2025
CompletedFirst Posted
Study publicly available on registry
December 4, 2025
CompletedAugust 13, 2026
August 1, 2026
3 months
November 23, 2025
August 11, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Concentration of high-sensitivity C-reactive protein (hsCRP)
High-sensitivity C-reactive protein (hsCRP) concentration will be measured to assess the inflammatory response.
1. Before training (at rest), 2. Immediately after training, 3. 24 hours after exercise.
Concentration of creatine kinase (CK)
Creatine kinase (CK) concentration will be measured as a biomarker of muscle damage and the physiological response to the training session.
1. Before training (at rest), 2. Immediately after training, 3. 24 hours after exercise.
Concentration of tumor necrosis factor-alpha (TNF-α).
Tumor necrosis factor-alpha (TNF-α) concentration will be assessed as a marker of the inflammatory response to training.
1. Before training (at rest), 2. Immediately after training, 3. 24 hours after exercise.
Concentration of interleukin-6 (IL-6).
Interleukin-6 (IL-6) concentration will be assessed as a marker of the inflammatory response to training.
1. Before training (at rest), 2. Immediately after training, 3. 24 hours after exercise.
Concentration of adrenaline
Adrenaline concentration will be assessed as a marker of the acute sympathoadrenal response to training.
1. Before training (at rest), 2. Immediately after training, 3. 24 hours after exercise.
Concentration of noradrenaline
Noradrenaline concentration will be assessed as a marker of the acute sympathoadrenal response to training.
1. Before training (at rest), 2. Immediately after training, 3. 24 hours after exercise.
Secondary Outcomes (4)
Concentration of cortisol
1. Before training (at rest), 2. Immediately after training, 3. 24 hours after exercise.
Concentration of total protein.
1. Before training (at rest), 2. Immediately after training, 3. 24 hours after exercise.
Concentration of urea.
1. Before training (at rest), 2. Immediately after training, 3. 24 hours after exercise.
Concentration of albumin.
1. Before training (at rest), 2. Immediately after training, 3. 24 hours after exercise.
Other Outcomes (1)
Concentration of uric acid.
1. Before training (at rest), 2. Immediately after training, 3. 24 hours after exercise.
Interventions
The intervention consists of a standardized, high-intensity wrestling training session designed to simulate typical strength-endurance exercise performed by elite wrestlers. The session includes sport-specific drills, resistance exercises, and aerobic conditioning components appropriate for this athletic discipline. All participants will perform the session under supervision to ensure safety and adherence to the planned intensity and duration.
Eligibility Criteria
The study participants are athletes from a national-level sports club who were also members of the national team. All athletes have experience competing in international events. The group includes athletes who have won medals at both national and international competitions. Participants are wrestling athletes specializing in strength-endurance training and represent the top competitive level in their sport. The study aims to evaluate acute physiological responses to a single high-intensity training session in this highly specialized discipline.
You may qualify if:
- Currently engaged in regular strength-endurance wrestling training.
- Medically cleared for high-intensity exercise by a sports physician.
- Willingness to participate and provide written informed consent.
- Availability to attend the training session and all blood sampling time points (pre-training, immediately post-training, 24 hours post-training).
You may not qualify if:
- Presence of acute or chronic illness that may affect exercise performance or physiological response.
- Recent musculoskeletal injury limiting participation in high-intensity training.
- Use of medications or supplements that may interfere with hormonal, inflammatory, or metabolic markers.
- History of endocrine disorders, adrenal insufficiency, or other conditions affecting catecholamine or cortisol levels.
- Inability or unwillingness to comply with study procedures.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Poznan University of Physical Education, Faculty of Sport Sciences in Gorzow Wielkopolski, Poland; Department of Biological Sciences.
Gorzów Wielkopolski, 66-400, Poland
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anna Kasperska, PhD
Poznan University of Physical Education, Faculty of Sport Sciences in Gorzow Wielkopolski, Poland;
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 23, 2025
First Posted
December 4, 2025
Study Start
February 1, 2014
Primary Completion
May 1, 2014
Study Completion
June 1, 2014
Last Updated
August 13, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share
IPD will not be shared to protect participant confidentiality and to meet ethical and legal standards regarding sensitive health and performance data.